Pride Capital Partners realizes exit of KAIROS to US listed IQVIA

KAIROS offers a unique combination of biobanking and clinical trial management software to European and North American university hospitals and research centers.

KAIROS in a nutshell

Investment year
> 40
Number of FTE
29 out of 35
German university hospitals use KAIROS software

Add-on acquisitions

No items found.


Do you want to know what we can do for you? Contact us!

Tavga Khezer Lal

Office Manager